GNH USA

Europe — EMA

Novantrone (Mitoxantrone)

GNH USA supplies Novantrone (Mitoxantrone), an antineoplastic for myeloid leukemia, acute lymphoblastic leukemia and breast cancer.

Mitoxantrone

Request sourcing

1
Pack/s

What is Mitoxantrone?

Mitoxantrone, the active ingredient in Novantrone, is a anthracenedione antineoplastic presented as an injection for intravenous use. It treats acute myeloid leukemia, acute lymphoblastic leukemia, metastatic breast cancer and is used off‑label for multiple sclerosis in adult patients.

GNH USA supplies Novantrone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Mitoxantrone used for?

Novantrone (mitoxantrone) is employed in the treatment of hematologic malignancies and selected solid tumours.

Acute myeloid leukemia: induces remission by targeting rapidly dividing leukemic cells. Acute lymphoblastic leukemia: contributes to disease control in relapsed or refractory cases. Metastatic breast cancer: provides disease stabilization in patients with prior therapy. Multiple sclerosis (off‑label): reduces relapse frequency in progressive forms.

What are the side effects of Mitoxantrone?

Mitoxantrone may cause a range of adverse reactions, varying from mild to potentially life‑threatening.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Fatigue: general tiredness. - Alopecia: temporary hair loss. - Myelosuppression: reduced blood cell counts.

Serious or Rare Side Effects: - Cardiotoxicity: irreversible reduction in left ventricular ejection fraction. - Severe myelosuppression: neutropenia or thrombocytopenia leading to infection or bleeding. - Secondary leukemia: emergence of therapy‑related acute leukemia. - Severe hypersensitivity: anaphylactic reactions.

What precautions apply to Mitoxantrone?

Key safety considerations should be observed when using Novantrone.

Monitor cardiac function: baseline and periodic echocardiograms are recommended. Assess blood counts: regular CBC to detect myelosuppression. Avoid use in pregnancy: drug is contraindicated due to fetal risk. Use with caution in hepatic impairment: dose adjustment may be required. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Mitoxantrone interact with?

Potential drug interactions require careful management.

Major Interactions (Avoid): - Anthracyclines: combined cardiotoxic risk may be additive. - Live vaccines: immunosuppression can increase infection risk. - CYP450 inhibitors: may increase mitoxantrone exposure (e.g., ketoconazole). - High-dose radiation therapy: enhanced tissue toxicity.

Moderate Interactions (Monitor Closely): - Anticoagulants: increased bleeding risk due to thrombocytopenia. - Other myelosuppressive agents: cumulative bone marrow suppression. - Hormonal therapies: potential additive effects on blood counts.

Frequently asked questions

What conditions is Novantrone used to treat?+
Novantrone (mitoxantrone) is indicated for the treatment of acute myeloid leukemia, acute lymphoblastic leukemia and metastatic breast cancer. In some regions it is also used off‑label for certain forms of multiple sclerosis.
How does mitoxantrone work in the body?+
Mitoxantrone intercalates into DNA and inhibits topoisomerase II, preventing DNA strand re‑ligation during replication. This causes double‑strand breaks, leading to apoptosis of rapidly dividing cancer cells.
How is the dose of Novantrone determined?+
The dose of Novantrone is set by the prescribing physician based on the specific indication, patient weight, renal and hepatic function, and prior treatment history. No standard dosing regimen is provided here.
Is Novantrone safe to use during pregnancy or while breastfeeding?+
Novantrone is classified as pregnancy category D, indicating evidence of fetal risk. It is generally contraindicated in pregnancy and not recommended during breastfeeding because it may be excreted in milk and harm the infant.
How do I order Novantrone from GNH USA?+
To order Novantrone, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.
How does Novantrone compare with other anthracycline drugs?+
Novantrone belongs to the anthracenedione subclass, sharing a DNA‑intercalating and topoisomerase‑II‑inhibiting mechanism with anthracyclines such as doxorubicin. Compared with traditional anthracyclines, mitoxantrone has a lower incidence of acute cardiotoxicity but still requires cardiac monitoring, especially at higher cumulative doses.
What are the recommended storage conditions for Novantrone?+
Novantrone should be stored at 2‑8 °C (refrigerated). Keep the vials in the original packaging, protect them from light, and do not freeze or shake the solution before administration.
How is Novantrone administered to patients?+
Novantrone is supplied as a sterile injectable solution for intravenous infusion. It is typically administered by a qualified healthcare professional in a clinical setting, following institutional protocols for infusion rate and monitoring.
What are the most serious risks associated with Novantrone therapy?+
The most serious risks include irreversible cardiotoxicity, severe myelosuppression leading to infection or bleeding, therapy‑related secondary leukemia, and severe hypersensitivity reactions such as anaphylaxis. Patients should be monitored closely for these events.
Who should not receive Novantrone?+
Novantrone is contraindicated in pregnant women, patients with pre‑existing severe cardiac disease, uncontrolled infections, and those with known hypersensitivity to mitoxantrone or any formulation component. Caution is also advised for individuals with significant hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Mitoxantrone
Route
Intravenous Use
Manufacturer
Viatris As
Origin
EU

Related products

Mitoxan

Mitoxan

Mitoxantrone

Medicamerc S.A
EU
Mitoxantron "ebewe"

Mitoxantron "ebewe"

Mitoxantrone

Ebewe Pharma
EU
Mitoxantron Accord

Mitoxantron Accord

Mitoxantrone

Accord Healthcare B.V.
EU
Mitoxantron Ebewe

Mitoxantron Ebewe

Mitoxantrone

Ebewe Pharma
EU